Thierry VandenDriessche

What is he best known for?

The fields of study he is best known for:

• Gene
• DNA
• Cancer

Thierry VandenDriessche mainly investigates Genetic enhancement, Virology, Molecular biology, Immunology and Viral vector. Thierry VandenDriessche has researched Genetic enhancement in several fields, including Vector, In vivo and Cell biology. His studies deal with areas such as Insertional mutagenesis, Transgene and Mutation as well as Virology.

The Molecular biology study combines topics in areas such as RNA, Gene, Mutant, Green fluorescent protein and Bone marrow. His Immunology study incorporates themes from Severe combined immunodeficiency and Gene delivery. His research combines Ex vivo and Viral vector.

His most cited work include:

• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions (1431 citations)
• Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates (609 citations)
• Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism (401 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Genetic enhancement, Immunology, Viral vector, Virology and Factor IX. His work investigates the relationship between Genetic enhancement and topics such as Cancer research that intersect with problems in Transfection. His Immunology research is multidisciplinary, incorporating perspectives in Clinical trial and In vivo.

His research in Viral vector intersects with topics in Molecular biology, Computational biology, Gene expression and Transduction. His Factor IX study results in a more complete grasp of Internal medicine. Thierry VandenDriessche interconnects Clotting factor and Stem cell in the investigation of issues within Gene delivery.

He most often published in these fields:

• Genetic enhancement (78.71%)
• Immunology (37.75%)
• Viral vector (38.15%)

What were the highlights of his more recent work (between 2016-2021)?

• Genetic enhancement (78.71%)
• Viral vector (38.15%)
• Gene (21.69%)

In recent papers he was focusing on the following fields of study:

Genetic enhancement, Viral vector, Gene, Bioinformatics and Factor IX are his primary areas of study. His Genetic enhancement study combines topics from a wide range of disciplines, such as Vector, Adeno-associated virus, Computational biology and Transgene. His research integrates issues of Promoter and Gene expression in his study of Transgene.

His Gene study improves the overall literature in Genetics. His Factor IX research incorporates themes from Vector, Antigen, Spleen, Hemophilias and Knockout mouse. His work carried out in the field of Transposable element brings together such families of science as Cellular differentiation and Induced pluripotent stem cell.

Between 2016 and 2021, his most popular works were:

• Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells. (38 citations)
• Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells. (38 citations)
• A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice (36 citations)

In his most recent research, the most cited papers focused on:

• Gene
• DNA
• Cancer

Thierry VandenDriessche mainly focuses on Viral vector, Genetic enhancement, Muscle disorder, Gene expression and Transgene. Thierry VandenDriessche has included themes like Bioinformatics, Transposable element, Transposase and Virology in his Viral vector study. His Transposable element study integrates concerns from other disciplines, such as Transfection and Induced pluripotent stem cell.

His study explores the link between Genetic enhancement and topics such as Computational biology that cross with problems in Cellular differentiation. His biological study spans a wide range of topics, including MBNL1, CRISPR, Follistatin, Promoter and Transduction. His Gene expression research is multidisciplinary, relying on both Haematopoiesis and Immune system, Antibody, Immune tolerance, Immunology.